| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |